PTGS2 and neoplasm: Our transgenic, macrophage-specific Cox-2 over-expression model provides the first direct evidence that increased stromal macrophage Cox-2 can drive ApcMin/+ mouse tumour progression in the colorectum, analogous to human colorectal polyp growth and malignant progression.